The clinical experiment found that the QLT granule inhibited the abnormal proliferation of synovial fibroblasts and the expression of receptor activator of nuclear factor-κB ligand (RANKL) in RA patients [9]. Here, TNFSF11 is linked to rheumatoid arthritis.